Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Assessment of NucleoCapture Selective DNA Adsorber in Humans

NCT04749238 is registered in ClinicalTrials.gov with Santersus AG as lead sponsor.

NCT NCT04749238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04749238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Assessment of NucleoCapture Selective DNA Adsorber in Humans
Lead sponsor
Santersus AG
Phase
Not applicable
Overall status
Completed
Start date
January 26, 2021
Completion date
October 24, 2021
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, sepsis-associated aki